arznei-telegramm Logo a-t Kurzlogo
    ❮ a-t 6/2022 a-t ❯
    This is a translation of the table of contents. One article of each issue is translated and freely available.
    table of contents
    SPOT ON

    Monkeypox in Europe

    PHARMACEUTICAL SUPPLY

    Supply shortage of relevant thrombolytics like alteplase (ACTILYSE): How could this happen?

    THERAPY FROM A CRITICAL VIEWPOINT

    Nirmatrelvir plus ritonavir (PAXLOVID) and molnupiravir (LAGEVRIO): observational data regarding omicron

    Sexually transmitted Chlamydia infections: azithromycin no longer treatment of choice

    a-t READERS QUESTIONS AND COMMENTS

    IMMUNOBON – a supplementary balanced diet against hayfever?

    Off label use of the anti-alcoholism drug disulfiram (ANTABUS, no longer marketed) against Lyme borreliosis?

    IN BRIEF

    Rucaparib (RUBRACA) – mislead by a surrogate endpoint

    SIDE EFFECTS

    Myocarditis/pericarditis with the protein-based SARS-CoV-2 vaccine NVX-CoV2373 (NUVAXOVID)
    free

    arznei-telegramm

    Independent drug information – in English

    Concise, critical evaluations of drugs and medical devices for evidence-based therapy and patient advice on benefits and risks – independent, ad-free and funded exclusively by subscriptions.

    Browse free articles

    Wir schätzen Ihr Feedback

    Nehmen Sie an unserer Umfrage teil!